Exhibit 99.3
Template for notification and public disclosure of transactions by persons discharging manage-rial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Adam Steensberg
2. Reason for the notification
a) Position/status EVP, Chief Medical and Development Officer in Zealand Pharma A/S
b) Initial notification/Amend- Initial notification
ment
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc-
tion monitor
a) Name Zealand Pharma A/S, CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial Shares
instrument, type of instru-
ment
Identification code DK0060257814
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
DKK 255,00 14.962
d) Aggregated information
- Aggregated volume DKK 3.815.310
- Price
e) Date of the transaction 28 May 2020
f) Place of the transaction Nasdaq Copenhagen A/S